One SCFA called butyrate boosts GLP-1
These prescription-based injections are administered weekly and act on the brains appetite centers, helping you feel full sooner and reducing cravings
They can advise you on whether its appropriate for you and recommend a dosage
The group was reviewing a paper on tirzepatide, a GLP-1 agonist, which reported that the drugs efficacy for weight loss was nearly comparable to that of bariatric surgery
What to do about new costs Depending on how the new research turns out, adding some of the indications discussed here could add many millions of potential patients who might benefit from GLP-1 medicines
If you need help broaching the subject, you can download a FREE toolkit, produced by the Obesity Action Coalition, at www.YourWeightMatters.org